By Katherine Hamilton
Akamai Technologies gave an adjusted earnings outlook that was lower than Wall Street expected. Shares fell 8% to $100.93 in after-hours trading Thursday.
Copart's fiscal second-quarter financial results were below estimates. The stock fell 9% to $34.24 after the bell.
Grail's cancer detection test failed to meet its primary endpoint during a trial. The stock dropped 48% to $53.13.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
February 19, 2026 18:45 ET (23:45 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.